Within a short 8-week observation period window, liraglutide induced a 2.6-point drop in PASI, which did not reach statistical significance compared to placebo.
← all excerpts
GLP-1 Receptor Agonists in Chronic Inflammatory Skin Diseases: Immunometabolic Mechanisms and Translational Perspectives.
1
—
—